A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations

NCT02782481 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Decision to change the study design

Conditions

Parkinson's Disease

Interventions

DRUG: ND0612
DRUG: Placebo

Sponsor

NeuroDerm Ltd.